SecBot SecBot
ANALYST-UPGRADE

CME

CME GROUP INC.
BULLISH
Impact 1/10
Horizonmonths Processed5mo ago SECanalyst-CME-rothschi-20260611
Rothschild & Co double upgrade: Neutral → Buy
Actionable Insight ▲ Bullish

The double upgrade is a bullish signal from a mid-tier firm, but traders should weigh it against heavy insider selling and descending EPS revisions. The stock may see a short-term pop, but the 55.3% short ratio and earnings on July 21 could amplify volatility. Wait for confirmation from volume and institutional flows before adding size.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$269.53
T+0 close · Jun 11, 2026 · via day close
Latest settled
+3.23%
T+60 · $278.23
Vs SPY
−0.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $269.53entry
  2. T+1 · 5mo ago −1.28%α −3.04% · $266.08
  3. T+5 · 5mo ago −8.59%α −9.26% · $246.38
  4. T+20 · 4mo ago −10.86%α −12.64% · $240.27
  5. T+60 · 2mo ago +3.23%α −0.04% · $278.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Rothschild & Co double-upgraded CME Group from Neutral to Buy on June 11, 2026, raising its price target to $323 from $316, implying 22.4% upside from the current $263.80. Rothschild has a 57% accuracy rate on 40 calls and an average return of 3.1%, placing it below the top-tier firms covering CME. Consensus is split: 10 Buy (48%), 8 Hold (38%), 3 Sell (14%) across 21 analysts, with a mean price target of $305.47. Rothschild' s $323 target is above both the mean and median ($310). Over the past 30 days, only 1 upgrade has occurred, while EPS revisions have been net negative (11 downward revisions for the current quarter, 11 for this fiscal year). Insider activity is mixed: CEO Terry Duffy sold $7.75M in mid-May, while an insider bought $418K in March. Institutional moves show Bank of America and Capital Research adding, but Price T Rowe and Renaissance trimming. Short interest is elevated at 55.3%. The next earnings report is due July 21, 2026. The bullish call from a moderately accurate firm faces headwinds from insider selling and downward estimate revisions, but the double-upgrade signal is rare and merits attention.

Impact Score

Base Score
1/7
LLM Adjustment
+0
Final Score
1/10

Consensus & Targets

Buy / Strong Buy
10 (48%)
Hold
8
Sell / Strong Sell
3
Total Analysts
15
Mean PT
$305.47
Median PT
$310.00
High PT
$353.00
Low PT
$230.00
Current Price
$263.80
Implied Upside
+15.8%

Of 21 analysts, 10 rate Buy (48%), 8 Hold (38%), 3 Sell (14%). The consensus leans bullish but is far from unanimous, with a notable hold camp reflecting caution. Rothschild's upgrade adds to the buy-side, which already is the largest single rating group.

Mean target $305.47, median $310, high $353, low $230. Current price of $263.80 implies 15.8% upside to the mean and 21.5% to the median. Rothschild's $323 target sits above both the mean and median, placing it in the upper third of the range. The high target of $353 (Morgan Stanley) suggests potential for further upside if earnings beat.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-06-11Rothschild & CoupgradeBuy$323.00
2026-04-23Morgan StanleymaintainOverweight$353.00
2026-04-23BarclaysmaintainEqual-Weight$316.00
2026-04-15Piper SandlermaintainOverweight$329.00
2026-04-13BarclaysmaintainEqual-Weight$343.00
2026-04-10Morgan StanleymaintainOverweight$362.00
2026-04-08BarclaysmaintainEqual-Weight$344.00
2026-03-04Argus ResearchdowngradeHoldNo target
2026-02-05JP MorganmaintainUnderweight$266.00
2026-02-05TD CowenmaintainBuy$328.00

Over the past 30 days, there has been 1 upgrade (Rothschild) and 0 downgrades. However, EPS estimate revisions have been decisively negative: current quarter (0Q) saw 0 upward and 11 downward revisions in 30 days; current fiscal year (0y) had 3 up and 11 down; next fiscal year (+1y) had 4 up and 7 down. The upgrade stands in contrast to the estimate consensus trending lower.

Firm Track Record: Rothschild & Co

Rothschild & Co accuracy: 57% on 40 calls | avg return: 3.1%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
UBS100%4/43.1%top tier
RBC Capital100%6/67.8%top tier
Deutsche Bank100%5/56.7%top tier
Piper Sandler89%8/98.5%top tier
Morgan Stanley88%7/86.1%top tier
Keefe, Bruyette & Woods75%6/87.6%top tier
Barclays71%10/145.6%top tier
Oppenheimer71%5/73.6%top tier
Citigroup60%3/54.9%above average
Raymond James50%1/20.7%below average

Rothschild & Co has a 57% accuracy on 40 calls with an average return of 3.1%. This is below the top-tier firms covering CME (UBS, RBC, Deutsche, Piper Sandler, Morgan Stanley all above 85% accuracy), but above the worst (JPMorgan and BofA have 0% accuracy on their CME calls). Rothschild is not among the most followed firms for CME, so its call may carry less weight.

Earnings Estimates

Next earnings: Jul 21, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$2.98$2.88 to $3.10$1.7B↑0 ↓0
+1y$12.91$11.85 to $13.61$7.3B↑1 ↓0
0y$12.27$11.91 to $12.62$7.0B↑1 ↓0
+1q$2.97$2.80 to $3.16$1.7B↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
1 buys / 4 sells
Institutional
PRICE T ROWE ASSOCIATES INC /MD/: trim (-30.1%)
Institutional
BANK OF AMERICA CORP /DE/: add (39.1%)
Institutional
Capital Research Global Investors: doubled (213.9%)
Short Interest
Short: 320,116 | Exempt: 73 | TRF Vol: 579,251 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)

Insider trades: CEO Terry Duffy sold $7.75M on May 15, and director Hilda Piell sold $1.75M on May 18, both sell-side signals opposing the bullish call. An insider purchase of $418K by William Shepard in March provides minor support. Institutional: Price T Rowe trimmed 30.1%, Bank of America added 39.1%, Capital Research doubled its position (+213.9%), while Renaissance trimmed 51.6% and Norges exited. Short interest is high at 55.3% of float, suggesting bearish sentiment. No congressional trades recorded. The analyst upgrade is divergent from insider selling but convergent with some institutional accumulation.

Investment Themes

Traditional Finance

Documents Analyzed

Report based on filing metadata.

Track record

29 reports on CME

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.81% at T+60 after the Mar 12, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $315.87 Now $319.37 +1.11% settles Feb 9
  2. Nov 9, 20267d ago 144 Neutral 1/10 Entry $304.52 Now $319.37 +4.88% settles Feb 5
  3. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $308.27 Now $319.37 +3.60% settles Feb 2
  4. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  5. Nov 2, 202614d ago 3 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $306.24 Now $319.37 +4.29% settles Jan 29
  8. Oct 27, 202620d ago Insider Cluster Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
  9. Oct 27, 202620d ago 144 Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
  10. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $305.71 Now $319.37 +4.47% settles Jan 21
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (11h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026